About Cipla Pharma And Life Sciences Limited
Data last updated: 23 December 2025
Cipla Pharma And Life Sciences Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Cipla Limited. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 20 August 2008, the company has been in operation for over 18 years.
Registered with ROC Mumbai under CIN U24239GA2008PLC007374.
Capital: an authorised share capital of ₹275 Cr and a paid-up capital of ₹258.71 Cr. Formerly known as Biomab Pharmaceuticals (India) Private Limited and Cipla Biotec Private Limited. It is led by directors including Anisha Naresh Udeshi and Sunil Jvalaprsad Gupta.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Tower A 1St Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,598.45 Cr, a decline of 2% compared to the previous year.
The company has a workforce of approximately 28 employees as per the latest available data. It operates as a subsidiary of Cipla Limited.
The company is associated with 1 brand - Cipla Biotec.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ciplabiotec.com.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social Media
-
Registered AddressTower A 1St Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013
-
IndustryPharma, Pharma Contract R&D
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Cipla Pharma And Life Sciences Limited
Cipla Pharma And Life Sciences Limited has undergone 3 name changes throughout its history. The company was previously known as Biomab Pharmaceuticals (India) Private Limited, Cipla Biotec Private Limited, and Mabpharm Private Limited. The current legal name is Cipla Pharma And Life Sciences Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Cipla Pharma And Life Sciences Limited | Current |
| Biomab Pharmaceuticals (India) Private Limited | Previous |
| Cipla Biotec Private Limited | Previous |
| Mabpharm Private Limited | Previous |
CIN History of Cipla Pharma And Life Sciences Limited
Cipla Pharma And Life Sciences Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239MH2008PLC381559, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239MH2008PLC381559 | Current |
| U24239GA2008PLC007374 | Previous |
| U24239MH2008PTC185974 | Previous |
| U24239GA2008PTC007374 | Previous |
Associated Brands with Cipla Pharma And Life Sciences Limited
Cipla Pharma And Life Sciences Limited operates one associated brand: Cipla Biotec. These brands represent Cipla Pharma And Life Sciences Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Monoclonal antibodies (mAb) to treat cancers & Wet Age-Related Macular Degeneration and Peptide hormone to treat diabetes. | ciplabiotec.com |
Competitors & Alternatives of Cipla Pharma And Life Sciences Limited
Brands and companies operating in the same space as Cipla Pharma And Life Sciences Limited include Xilio Therapeutics, Ambrx, Harbour BioMed and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Xilio Therapeutics
|
Tumor-selective immunotherapies for cancer treatment are developed. | Waltham, United States, United States | 2016 |
Ambrx
|
Antibody-drug conjugates are developed for cancers and metabolic disorders. | San Diego, United States, United States | 2003 |
Harbour BioMed
|
Antibody therapeutics are developed for immunology and oncology diseases. | Shanghai, China, China | 2016 |
BioAtla
|
Immunotherapies for cancer are developed using conditionally active biologics platform. | San Diego, United States, United States | 2007 |
Zymeworks
|
Bi-specific antibodies and antibody-drug conjugates are developed for cancer treatment. | Vancouver, Canada, Canada | 2003 |
Merus
|
Antibody-based drugs for cancer treatment are developed using bispecific engineering. | Utrecht, Netherlands, Netherlands | 2003 |
PharmAbcine
|
Monoclonal antibodies are developed for cancer and inflammatory disease treatments. | Daejeon, South Korea, South Korea | 2008 |
Leap Therapeutics
|
Novel immuno-oncology therapeutics are acquired and developed for clinical advancement. | Cambridge, United States, United States | 2011 |
Lassen Therapeutics
|
Biotherapeutics targeting cancer via interleukin-11 are developed. | San Diego, United States, United States | 2019 |
Business Activity of Cipla Pharma And Life Sciences Limited
Cipla Pharma And Life Sciences Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details for Cipla Pharma And Life Sciences Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Cipla Pharma And Life Sciences Limited
Cipla Pharma And Life Sciences Limited is currently managed by 5 directors, with 19 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anisha Naresh Udeshi | Director | 08 Jun 2020 | 6 Years 1 Months | Current |
|
Sunil Jvalaprsad Gupta
Also directs:
Inzpera Healthsciences Limited
|
Managing Director | 02 Feb 2024 | 2 Years 5 Months | Current |
| Jinesh Chauhan | Whole-Time Director | 01 Apr 2023 | 3 Years 3 Months | Current |
|
Rajendra Kumar Chopra
Also directs:
Meditab Specialities Limited, Goldencross Pharma Limited, Cipla Pharmaceuticals Limited and 3 more
|
Director | 02 Jan 2019 | 7 Years 6 Months | Current |
| Raju Sunil Mistry | Additional Director | 01 Jun 2025 | 1 Years 1 Months | Current |
Financials of Cipla Pharma And Life Sciences Limited FY 2025 filings available
Cipla Pharma And Life Sciences Limited reported revenue of ₹1,598.45 Cr (down 2.00% YoY) for FY 2025.
Ten-year financial statements for Cipla Pharma And Life Sciences Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings Cipla Pharma And Life Sciences Limited
Cipla Pharma And Life Sciences Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Cipla Pharma And Life Sciences Limited
View historical data on people associated with Cipla Pharma And Life Sciences Limited, including employment history and EPFO contributions.
Employee and EPFO history for Cipla Pharma And Life Sciences Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Cipla Pharma And Life Sciences Limited
GST registrations and filing compliance for Cipla Pharma And Life Sciences Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Cipla Pharma And Life Sciences Limited
Credit ratings, litigation, and regulatory alerts for Cipla Pharma And Life Sciences Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cipla Pharma And Life Sciences Limited
MSME payment history for Cipla Pharma And Life Sciences Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cipla Pharma And Life Sciences Limited
Corporate group structure for Cipla Pharma And Life Sciences Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cipla Pharma And Life Sciences Limited
MCA filings and documents for Cipla Pharma And Life Sciences Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Cipla Pharma And Life Sciences Limited
Recent News on Cipla Pharma And Life Sciences Limited
Frequently Asked Questions about Cipla Pharma And Life Sciences Limited
Cipla Pharma And Life Sciences Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 20 August 2008 (18+ years old) and is registered under CIN U24239MH2008PLC381559. The company has 28 employees.
Cipla Pharma And Life Sciences Limited reported revenue of ₹1,598.45 Cr for FY 2025 (down 2.00% YoY).
The current directors of Cipla Pharma And Life Sciences Limited are:
- Anisha Naresh Udeshi - Director
- Sunil Jvalaprsad Gupta - Managing Director
- Jinesh Chauhan - Whole-Time Director
- Rajendra Kumar Chopra - Director
- Raju Sunil Mistry - Additional Director
The primary industry of Cipla Pharma And Life Sciences Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.
Cipla Pharma And Life Sciences Limited can be reached at the registered office: Tower A 1St Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013, or through the website ciplabiotec.com.
The authorised capital is ₹275 Cr, and the paid-up capital is ₹258.71 Cr.